Life Sciences

FDA issues final guidance on submissions of PMA supplements

Device Regulation Alert: Safety, Compliance and Reimbursement News, December 22, 2008

The FDA provided new criteria for medical device manufacturers to determine what type of pre-market application (PMA) to submit for changes involving class III devices.

Post a Comment





Please enter your comment below:


Please enter the text below:

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Complete Guide to Lab Safety, 3rd Ed.

    The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...

Most Popular